CLINICAL_TRIALS trial_result · 2021-02-24

Clinical Trial Update: A Study Of The Analgesic (Pain-Relief) Effects Of Tanezumab In Adult Patients With Diabetic Peripheral Neuropathy [Phase 2]

A Phase 2 study assessing the analgesic effects of tanezumab in adults with diabetic peripheral neuropathy was terminated with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Sponsor: Pfizer | Conditions: Diabetic Peripheral Neuropathy | Phase 2 | Status: TERMINATED | Results posted: 2021-02-24